D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Pfizer
PFE
|
+$439M |
| 2 |
AbbVie
ABBV
|
+$401M |
| 3 |
Johnson & Johnson
JNJ
|
+$308M |
| 4 |
Gilead Sciences
GILD
|
+$261M |
| 5 |
Mercado Libre
MELI
|
+$259M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$391M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$390M |
| 3 |
Citigroup
C
|
+$315M |
| 4 |
PayPal
PYPL
|
+$282M |
| 5 |
SHPG
Shire pic
SHPG
|
+$276M |
Sector Composition
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Healthcare | 16.62% |
| 4 | Financials | 9.01% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FCRD
1701
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $1.32M | ﹤0.01% |
200,937
+146,146
| +267% | +$959K |
|
|
I
1702
DELISTED
INTELSAT S. A.
I
| $1.32M | ﹤0.01% |
84,020
-209,842
| -71% | -$3.29M |
|
1703
American Express
AXP
$226B
| $1.31M | ﹤0.01% |
12,019
+1,362
| +13% | +$149K |
|
1704
Domo
DOMO
$689M
| $1.31M | ﹤0.01% |
32,557
+14,576
| +81% | +$588K |
|
1705
Lexicon Pharmaceuticals
LXRX
$407M
| $1.31M | ﹤0.01% |
236,121
-32,355
| -12% | -$180K |
|
|
IMGN
1706
DELISTED
Immunogen Inc
IMGN
| $1.31M | ﹤0.01% |
+483,839
| New | +$1.31M |
|
1707
Old Dominion Freight Line
ODFL
$30.6B
| $1.31M | ﹤0.01% |
27,153
-10,533
| -28% | -$507K |
|
1708
Lands' End
LE
$465M
| $1.3M | ﹤0.01% |
78,144
+57,792
| +284% | +$960K |
|
1709
Nova
NVMI
$8.7B
| $1.3M | ﹤0.01% |
+51,529
| New | +$1.3M |
|
|
SYKE
1710
DELISTED
SYKES Enterprises Inc
SYKE
| $1.3M | ﹤0.01% |
45,825
-7,518
| -14% | -$213K |
|
|
AKCA
1711
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $1.29M | ﹤0.01% |
+45,676
| New | +$1.29M |
|
1712
Grupo Aval
AVAL
$4.02B
| $1.29M | ﹤0.01% |
164,949
-66,919
| -29% | -$521K |
|
1713
SLR Investment Corp
SLRC
$878M
| $1.29M | ﹤0.01% |
61,645
+49,898
| +425% | +$1.04M |
|
1714
Helix Energy Solutions
HLX
$920M
| $1.28M | ﹤0.01% |
162,336
+16,800
| +12% | +$133K |
|
|
SMI
1715
DELISTED
Semiconductor Manufacturing Intl
SMI
| $1.28M | ﹤0.01% |
253,751
+83,187
| +49% | +$421K |
|
1716
Crane NXT
CXT
$3.47B
| $1.28M | ﹤0.01% |
43,585
-13,612
| -24% | -$400K |
|
1717
Zions Bancorporation
ZION
$8.64B
| $1.28M | ﹤0.01% |
+28,193
| New | +$1.28M |
|
|
LTXB
1718
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $1.28M | ﹤0.01% |
34,236
+22,912
| +202% | +$857K |
|
1719
Liberty Latin America Class A
LILA
$1.5B
| $1.27M | ﹤0.01% |
+69,898
| New | +$1.27M |
|
|
AQ
1720
DELISTED
Aquantia Corp. Common Stock
AQ
| $1.27M | ﹤0.01% |
+140,347
| New | +$1.27M |
|
|
ADAP
1721
Adaptimmune Therapeutics
ADAP
$14M
| $1.27M | ﹤0.01% |
294,573
+80,412
| +38% | +$346K |
|
1722
The GEO Group
GEO
$3.14B
| $1.27M | ﹤0.01% |
65,900
-520,498
| -89% | -$9.99M |
|
1723
VEON
VEON
$3.67B
| $1.26M | ﹤0.01% |
+24,187
| New | +$1.26M |
|
1724
Allegion
ALLE
$15.1B
| $1.26M | ﹤0.01% |
13,900
-9
| -0.1% | -$816 |
|
1725
Aqua Metals
AQMS
$5.17M
| $1.26M | ﹤0.01% |
+2,054
| New | +$1.26M |
|